Prompt

Can you recommend generic API manufacturers for comparing supplier quality and pricing on a new sourcing program?

Pharmaceuticals / Generic Pharma2 observationsLast seen Oct 7, 2026

Latest observation

Oct 7, 2026OpenAI APIWeb search: off

Yes — if you’re building a new sourcing program, it’s smart to compare API manufacturers across quality systems, regulatory footprint, scale, cost, and supply reliability. Below is a practical shortlist of well-known generic API manufacturers you can benchmark. I’ll keep this at a supplier-evaluation level rather than a product-specific recommendation, since the “best” option depends heavily on the API, dosage form, market, and regulatory target.

Large / established generic API manufacturers to compare

India

These are often strong on cost competitiveness and broad portfolio coverage:

  • Aurobindo Pharma
  • Laurus Labs
  • Sun Pharma / Taro-related API footprint
  • Divi’s Laboratories
  • Dr. Reddy’s Laboratories
  • Granules India
  • Shilpa Medicare / Shilpa Biologicals
  • Neuland Laboratories
  • Hetero
  • Macleods Pharmaceuticals (select API capabilities)

Europe

Often stronger on regulatory maturity, controlled substances, and specialty chemistry:

  • Siegfried
  • BASF Pharma Solutions (selected intermediates/ingredients, not broad generic API in all cases)
  • EuroAPI
  • Polpharma API
  • Olon
  • Lonza (more CDMO/complex APIs than generic-only)
  • Cambrex
  • Demo S.A.
  • Olainfarm / Olpha (depending on current commercial scope)

China

Usually strong on scale and cost, but quality/regulatory diligence is critical:

  • Zhejiang Huahai
  • Aarti drugs / manufacturers with China supply chains (case-dependent)
  • Porton Pharma Solutions
  • Asymchem
  • Zhejiang Hongyuan
  • CSPC API subsidiaries
  • Jiangsu Hengrui (select API capabilities)
  • Shandong-related bulk API producers (evaluate case-by-case)

Global / specialty API players

Useful if your program includes complex chemistry, HPAPI, or difficult-to-make molecules:

  • Cambrex
  • Siegfried
  • Lonza
  • Asymchem
  • Porton Pharma Solutions
  • Hikal
  • Dishman Carbogen Amcis
  • Piramal Pharma Solutions

What to compare beyond price

For a sourcing program, I’d recommend scoring each manufacturer on:

1) Quality system

  • FDA / EMA / MHRA inspection history
  • Warning letters / import alerts / 483 observations
  • GMP compliance maturity
  • Data integrity track record
  • OOS / deviation / CAPA performance

2) Regulatory support

  • DMF/ASMF availability
  • CEP support if relevant
  • Change notification discipline
  • Technical package quality
  • Audit responsiveness

3) Supply reliability

  • Multi-site manufacturing redundancy
  • Capacity utilization
  • Lead times and flexibility
  • Raw material dependence
  • Business continuity planning

4) Cost structure

  • API unit price
  • MOQ and lot sizes
  • Freight / duties / INCOTERMS
  • Inventory holding cost
  • Costs from quality failures or revalidation

5) Technical fit

  • Particle size, polymorph, impurity profile
  • Sterility / micronization / containment needs
  • HPAPI or hazardous handling
  • Impurity control and stability profile

A practical way to build your shortlist

For a new sourcing program, I’d usually create a matrix with 5–10 suppliers and group them like this:

  • Low-cost / high-volume option: typically Indian or Chinese bulk API producers
  • Balanced quality + cost option: strong Indian/EU manufacturers
  • Premium / backup / difficult chemistry option: EU, US, or specialty CDMOs

That way you can compare:

  • Primary source
  • Dual source
  • Strategic backup source

Suggested initial RFQ/Audit questions

If helpful, your RFQ should ask for:

  • Annual nameplate capacity and current loading
  • Site list and exact manufacturing step ownership
  • GMP certifications and last inspection dates
  • DMF/ASMF/CEP status
  • Typical lead time and minimum order quantity
  • Impurity profile and control strategy
  • Change notification policy
  • History of supply interruptions in the last 3 years
  • Price breaks by volume
  • Validation batch availability and sample lead time

If you want a more useful answer

I can also give you one of these:

  1. a ranked shortlist by region and quality tier,
  2. a supplier scorecard template in Excel-style format, or
  3. a list tailored to a specific API category like sterile injectables, oral solids, HPAPI, or controlled substances.

If you tell me the API type, target market (US/EU/ROW), and approximate annual volume, I can narrow this to a much more actionable supplier list.

Observation history

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (2 observations for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, Meta AI, Qwen.

How can brands improve their AEO?

Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.

Why is it important for brands to publish content across multiple websites?

Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.

Want this interpreted for your brand?

Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.